Dynavax's Z-1018 shingles vaccine matched Shingrix in immune response with fewer side effects, advancing to Phase 2 in older adults in 2025.

Shares of Dynavax rose after the company released positive results from a trial of its shingles vaccine tested against current Shingles vaccine Shingrix. The stock was up 6.7% to $11.12 but is still ...

Dynavax’s lofty ambition to snatch Shingrix’s crown got off to a promising start after the biopharma’s investigational shingles vaccine held its own against GSK’s mainstay in the first part of a phase ...

The company said that it now intends to advance Z-1018 into the next part of the study in adults 70 years of age and older in ...

Dynavax Technologies said on Thursday its experimental shingles vaccine generated a similar immune response as GSK's blockbuster shot Shingrix, while showing a better safety profile, in an ...

Who should get a shingles vaccine? The CDC recommends two doses of recombinant zoster vaccine (RZV, Shingrix) to prevent shingles and related complications in all adults 50 years and older. Dr.

Shingles—also known as herpes zoster—is caused by the varicella-zoster virus, the same one that causes chickenpox. If you had that malady as a kid, you’re at risk for a case of shingles ...

Sen. Dianne Feinstein of California, age 89, is home from the hospital recovering from a bout of shingles. Here's what to know about the painful rash caused by a virus.

The rash typically develops on one side of the body or face and forms blisters that scab over in 7–10 days, usually healing within two to four weeks. While shingles is more common in older adults, it ...

The weight of the asphalt shingles stacked on the rooftop was too much, it caused the roof and the walls to collapse, he said. "I couldn't believe it," he said. It is a modest house.

Shingles will strike 1 in 3 Americans during their lifetimes — most between ages 60 and 70. Folks in their 60s get shingles at roughly twice the rate as folks in their 50s, reports the CDC.

Although shingles vaccination rates have inched upward in recent years, only a third of adults who were 60 or older in 2016 had received the Zostavax vaccine, the CDC says.